Mylan has launched a biosimilar version of Sanofi’s best-selling insulin, Lantus, that it says is priced 65 percent lower than comparable insulins. The biosimilar, called Semglee, costs $147.98 for a ...
Citing an “unprecedented” operating environment due to the COVID-19 pandemic, Mylan said Robert Coury will return to his role as executive chairman. Mr. Coury served as Mylan’s executive chairman ...
Pfizer, Mylan escape another EpiPen lawsuit after judge scraps pharmacy chain's antitrust complaints
Mylan and Pfizer have spent years defending their marketing of the popular epinephrine injector EpiPen. After a busy couple of months in court, the partners have now wiped their hands of another ...
STATEWIDE — New York Attorney General Letitia James’ office has helped to secure a multistate settlement in principle with the successor company of pharmaceutical manufacturer Mylan Inc. that will ...
Mylan Pharmaceuticals is pulling a batch of Xanax from pharmacy shelves nationwide because of what the company said is "the potential presence of a foreign substance" in the popular prescription ...
PITTSBURGH — Mylan has launched a generic drug for fungal infections, the company said Tuesday. Mylan announced the launch, through subsidiary Mylan Pharmaceuticals, of voriconazole tablets in the ...
HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that Bill Szablewski, CFA, has joined the company as Head of Capital Markets, in a new ...
Shares of generic drug manufacturers rose Friday following a report Amazon.com Inc. has held conversations with Mylan NV and Sandoz, a Novartis AG unit, about potentially entering the pharmacy market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback